Medicare Enrolled
Dr. Jane Iluba, MD
MOHS-Micrographic Surgery Physician · Athens, GA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Iluba from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Iluba?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Iluba
Dr. Jane Iluba is a mohs-micrographic surgery physician in Athens, GA, with 16 years of NPI registration. Based on federal Medicare data, Dr. Iluba performed 2,609 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Iluba received a total of $5,078 from 35 pharmaceutical and/or device companies across 246 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Iluba is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 16 years of NPI registration
▲ 2,609 Medicare services
$5,078 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗2,609
Medicare services
Bottom 43% in GA for mohs-micrographic surgery physician
Not available
Unique patients (not deduplicated)
$56
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Destruction of precancerous skin growths, 2-14 This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer. |
1,018 | $5 | $15 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
286 | $37 | $130 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
276 | $35 | $153 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
273 | $62 | $209 |
| Destruction of skin growths (warts/lesions), 1-14 This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface. |
184 | $75 | $256 |
| Skin biopsy, tangential A procedure to remove a sample of the first identified skin growth for laboratory examination. |
147 | $58 | $229 |
| Skin growth removal and lab exam, 1-5 blocks This procedure involves the removal of a growth from the head, neck, hands, feet, or genitals. The removed tissue is then examined under a microscope in the laboratory. |
83 | $486 | $1,548 |
| Additional skin growth biopsy Removal of a sample of an additional skin growth for laboratory examination. This code is used for each extra lesion biopsied during the same session. |
55 | $35 | $116 |
| Destruction of 15 or more precancerous skin growths This procedure involves the removal or destruction of fifteen or more precancerous skin lesions. It is performed to treat abnormal skin cells that have the potential to develop into cancer. |
52 | $119 | $385 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
43 | $86 | $296 |
| Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | 41 | $305 | $935 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
40 | $72 | $260 |
| New patient office visit, 15-29 minutes An initial office visit for a new patient lasting 15 to 29 minutes. This code is used when the total time spent on the date of the encounter meets this duration threshold. |
33 | $36 | $167 |
| Complicated wound repair, 2.6-7.5 cm A complex surgical procedure to close a wound measuring between 2.6 and 7.5 centimeters on areas such as the face, neck, hands, or feet. |
26 | $178 | $1,084 |
| Intermediate wound repair, 2.6-7.5 cm A medical procedure to close a wound on the scalp, underarms, trunk, arms, or legs that measures between 2.6 and 7.5 centimeters. This type of repair involves cleaning the wound and stitching it closed to promote healing. |
24 | $209 | $761 |
| Surgical removal of skin cancer, 1.1-2.0 cm Surgical excision of a cancerous skin growth measuring between 1.1 and 2.0 centimeters on the body, arms, or legs. |
17 | $135 | $560 |
| Punch biopsy of first skin growth A small, circular piece of skin is removed from a skin growth using a circular blade. The sample is then sent to a laboratory for examination. |
11 | $85 | $285 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$5,078
Total received (2018-2024)
Avg $725/year across 7 years
Top 50% in GA for mohs-micrographic surgery physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
35
Companies
246
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,989
2023
$1,266
2022
$550
2021
$578
2020
$295
2019
$286
2018
$114
Payments by company (2024)
GENZYME CORPORATION
$417
Janssen Biotech, Inc.
$280
ABBVIE INC.
$256
LEO Pharma Inc.
$163
Amgen Inc.
$104
UCB, Inc.
$98
PFIZER INC.
$97
Incyte Corporation
$93
Lilly USA, LLC
$91
Regeneron Healthcare Solutions, Inc.
$82
SUN PHARMACEUTICAL INDUSTRIES INC.
$73
Galderma Laboratories, L.P.
$55
Dermavant Sciences, Inc.
$50
Ortho Dermatologics, a division of Bausch Health US, LLC
$37
Boehringer Ingelheim Pharmaceuticals, Inc.
$25
Almirall LLC
$24
Verrica Pharmaceuticals Inc.
$22
Novartis Pharmaceuticals Corporation
$21
Top 3 companies account for 47.9% of 2024 payments
All-time payments by company (2018-2024) ›
GENZYME CORPORATION
$591
Janssen Biotech, Inc.
$500
AbbVie Inc.
$409
LEO Pharma Inc.
$375
Regeneron Healthcare Solutions, Inc.
$374
Lilly USA, LLC
$362
ABBVIE INC.
$277
UCB, Inc.
$236
Incyte Corporation
$210
Amgen Inc.
$208
Ortho Dermatologics, a division of Bausch Health US, LLC
$167
PFIZER INC.
$161
Sun Pharmaceutical Industries Inc.
$149
Celgene Corporation
$116
Galderma Laboratories, L.P.
$115
E.R. Squibb & Sons, L.L.C.
$105
Almirall LLC
$104
Encore Dermatology Inc.
$93
SUN PHARMACEUTICAL INDUSTRIES INC.
$73
Dermavant Sciences, Inc.
$71
Boehringer Ingelheim Pharmaceuticals, Inc.
$66
Genentech USA, Inc.
$49
Paratek Pharmaceuticals, Inc.
$36
Novartis Pharmaceuticals Corporation
$33
VYNE Pharmaceuticals Inc.
$32
EPI Health, LLC
$27
Verrica Pharmaceuticals Inc.
$22
Biofrontera Inc.
$20
Nabriva Therapeutics, plc
$19
Aclaris Therapeutics, Inc.
$15
Bayer HealthCare Pharmaceuticals Inc.
$14
Janssen Scientific Affairs, LLC
$12
MAYNE PHARMA INC.
$12
AbbVie, Inc.
$12
Integra LifeSciences Corporation
$12
Top 3 companies account for 29.5% of all-time payments
Associated products mentioned in payments ›
ABSORICA LD · ADBRY · AKLIEF · ALTRENO · AMELUZ · AMZEEQ · ARAZLO · BLU-U · BOTOX · Bimzelx · CLODERM · COSENTYX · Cimzia · Cordran · DUOBRII · DUPIXENT · ENSTILAR · EPSOLAY · EUCRISA · Enbrel · Erivedge · Finacea · Humira · ILUMYA · INTEGRA MESHED BILAYER WOUND MATRIX · Impoyz · Klisyri · LIBTAYO · NUZYRA · OLUMIANT · OPZELURA · ORACEA · Odomzo · Otezla · RHOFADE · RINVOQ · SILIQ · SKYRIZI · SOOLANTRA · SPEVIGO · Sivextro · Sotyktu · TALTZ · TREMFYA · VTAMA · Winlevi · YCANTH · ZILXI
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Mohs-micrographic surgery physicians in nearby ZIP areas
2
County median income
$52,267
Nearest hospital to ZIP centroid (approximate)
ST MARY'S HOSPITAL
6.4 mi
6.4 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Iluba is a clinical cardiology specialist, with moderate Medicare volume, with 16 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Iluba experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Iluba performed 1,018 destruction of precancerous skin growths, 2-14 services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Iluba receive payments from pharmaceutical companies?
Yes. Dr. Iluba received a total of $5,078 from 35 companies across 246 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Iluba's costs compare to other mohs-micrographic surgery physicians in Athens?
Dr. Iluba's average Medicare payment per service is $56. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Iluba) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Mohs-Micrographic Surgery Physicians in Athens
Browse mohs-micrographic surgery physicians in Athens ranked by procedure volume and transparency data.
Highest volume
Top Mohs-Micrographic Surgery Physicians in GA
Mohs-micrographic surgery physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Mohs-Micrographic Surgery Physicians in GA
Which GA mohs-micrographic surgery physicians receive the most from drug and device companies.
By company
GENZYME CORPORATION Payments to Doctors
See all physicians who received payments from GENZYME CORPORATION.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
AbbVie Inc. Payments to Doctors
See all physicians who received payments from AbbVie Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology